Study S001423

Short Term Weight Loss With Liraglutide and Metformin Before IVF in Infertile Obese PCOS Patients

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT03034941
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 35
Start: 2014-04
Primary completion: 2016-12
Lead sponsor: University Medical Centre Ljubljana
Conditions: Obesity; PCOS
Interventions: DRUG:Metformin; DRUG:Liraglutide + metformin
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

The main outcome was change in BMI [Patient's BMI was measured at the beginning and every four weeks during 12 weeks of clinical trial.]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0018103	Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin. Jensterle Sever M, European journal of endocrinology	2014	Randomized trial	PMID 24362411 DOI	registry reference BACKGROUND:24362411